The SMi Group announced its 20th Annual Pain Therapeutics conference to be held in London on the 11th and 12th May 2020.

The Global Pain Therapeutics Market was valued at $11.26 Million in 2018 and is projected to reach $15.87 Million by 2026, growing at a CAGR of 4.40 % from 2019 to 2026. Improving pain management continues to be a priory as pain-derived disabilities such as osteoarthritis, back pain, migraines and cancer are leading cause of disability worldwide. Yet, pain treatment remains the biggest clinical burden of the age as a result of lack of efficacy, increasing side effects and the opioid crisis that is now entering Europe following its epidemic in the USA.

The 20th Annual Conference will overview the current state of pain treatment highlighting clinical success to date as well as evaluating the potential of drug candidates in the pipelines.

Why should you attend?

• Network with leading pharmaceutical companies and academic researchers of the pain community

• Rethink pain research by exploring novel biomarkers, sex differences in nociception, pain clinical trial design and novel targets

• Improve your understanding of neuro-immune interactions and their role in pain pathology, a promising new angle of pain research

For further information and conference programme, please visit the official website of the event.